JWM
RCKT icon

JPL Wealth Management’s Rocket Pharmaceuticals RCKT Stock Holding History

JPL Wealth Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226 Buy
66
+22
+50% +$73 ﹤0.01% 1515
2026
Q1 		$158 Buy
+44
New +$175 ﹤0.01% 1435

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

JPL Wealth Management's RCKT Position: Q2 2026 in Review

JPL Wealth Management increased its Rocket Pharmaceuticals (RCKT) stake by 50% in Q2 2026, buying an estimated $73 and bringing the position to 66 shares worth $226. The position accounts for ﹤0.01% of the portfolio, ranked #1515.

JPL Wealth Management first reported a position in RCKT in Q1 2026 and has held it in 2 quarters since. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • JPL Wealth Management held 66 shares of Rocket Pharmaceuticals worth $226 as of Q2 2026.
  • JPL Wealth Management bought 22 Rocket Pharmaceuticals shares in Q2 2026, an estimated $73.
  • Rocket Pharmaceuticals made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1515 holding.
  • JPL Wealth Management first reported a position in Rocket Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.